Varied Mutation Prevalence in Multiple Colorectal Adenomas

This article originally appeared here.
Share this content:
Varied Mutation Prevalence in Multiple Colorectal Adenomas
Varied Mutation Prevalence in Multiple Colorectal Adenomas

(HealthDay News) – For patients with multiple colorectal adenomas, there is considerable heterogeneity in the prevalence of pathogenic APC and MUTYH mutations, which varies by adenoma count, according to a study published in the Aug. 1 issue of the Journal of the American Medical Association.

Shilpa Grover, MD, MPH, from Brigham and Women's Hospital in Boston, and colleagues examined the prevalence of pathogenic APC and MUTYH mutations in 8,676 patients with multiple colorectal adenomas. Participants had undergone full gene sequencing and large rearrangement analysis of the APC gene, with targeted sequence analysis for the 2 most common MUTYH mutations (Y179C and G396D). Full MUTYH gene sequencing was conducted in individuals with either mutation.

The researchers found that 7,225 individuals had colorectal adenomas (1,457 patients had classic polyposis with ≥100 adenomas and 3,253 had attenuated polyposis with 20 to 99 adenomas). The prevalence of pathogenic APC and bilallelic MUTYH mutations was 80 and 2%, respectively, for those with 1,000 or more adenomas; 56 and 7%, respectively, for those with 100 to 999 adenomas; 10 and 7%, respectively, for those with 20 to 99 adenomas; and 5 and 4%, respectively, for those with 10 to 19 adenomas. In multivariable analyses, adenoma count correlated strongly with a pathogenic mutation.

"The mutation probabilities reported here may assist clinicians in their decision to recommend genetic evaluation and counsel patients undergoing genetic testing," the authors write.

Several authors disclosed financial ties to diagnostic and health care companies, including Myriad Genetic Laboratories, which forwarded data sets to the independent investigators.

Full Text

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs